No insider purchase over the last 90 days. The latest, by 이창진, was filed 23 Apr 2026.
Laseroptek Co., Ltd.: what insiders have been doing
Laseroptek Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through DART (FSS). Between 2 November 2025 and 2 November 2026, 8 insiders published 17 filings.
The record shows 8 purchases on the open market worth €682k, made by 4 insiders, against 2 sales worth €217k by 2 insiders. No amount is published for 3 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €362k, bought by 주홍 and made public on 30 March 2026 (1.5% of market cap). On the buying side, the filings list 2 chief executives, 1 board member and 1 senior executive among the declarants.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 17 filings here. Our records for Laseroptek Co., Ltd. go back to 2024, with 23 purchases and 11 sales on the open market in total.
In the case of 5 purchases, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The last insider purchase was made public on 23 April 2026, 201 days ago. The median gap between a trade and its publication by DART (FSS) is 13 days. The shorter that gap, the sooner other investors can see what insiders have done.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySale+3 other insiders
Since the insiders bought
- -51.0%Entry ₩5,720 · Close 30 Oct 2026 ₩2,800
- -51.0%Entry ₩5,720 · Close 30 Oct 2026 ₩2,800
- -51.0%Entry ₩5,720 · Close 30 Oct 2026 ₩2,800
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- 68,437 shares0.91% mcap18.3% of flowKRXDART:20260429001110
- 664,440 shares@ ₩2,500.46034.07% mcap81.7% of flowShareKRXDART:20260429001106
- 3,749 shares0.051% mcap2.5% of flowKRXDART:20260423000320Canonical exit: 16 Jul 2026 (T+90)
- 25,020 shares@ ₩3,965.000.084% mcap100.0% of flowShareKRXDART:20260423000341Canonical exit: 15 Jun 2026 (T+90)
- 154,304 shares@ ₩3,965.000.74% mcap100.0% of flowShareKRXDART:20260423000337Canonical exit: 16 Jul 2026 (T+90)
- 95,585 shares@ ₩3,965.000.47% mcap23.2% of flowShareKRXDART:20260423000329Canonical exit: 16 Jul 2026 (T+90)
- 64 shares@ ₩3,965.000.0002% mcap100.0% of flowShareKRXDART:20260423000356Canonical exit: 15 Jun 2026 (T+90)
- 0KRXDART:20260413002412
- 111,070 shares1.52% mcap74.4% of flowKRXDART:20260330001107Canonical exit: 21 Jun 2026 (T+90)
- 10,518 sharesShareKRXDART:20260330001206
- 872,448 sharesShareKRXDART:20260330001136Canonical exit: 15 Jun 2026 (T+90)
- 7,026 sharesShareKRXDART:20260330001176
- 77,152 sharesShareKRXDART:20260330001152Canonical exit: 15 Jun 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20260220001309
- 1,209,998 sharesKRXDART:20260203000261
- ●Executives0DART
- 221,000 sharesShareKRXDART:20250530002148Canonical exit: 28 Aug 2025 (T+90)
- 80,000 sharesKRXDART:20250528000149
- 80,000 sharesShareKRXDART:20250528000156
- 180,000 sharesKRXDART:20250310000498
25 of 50 declarations
About Laseroptek Co., Ltd.
레이저옵텍 is a company listed on the XKRX, specializing in the health and pharmaceutical sector. It focuses on developing innovative technologies and products for the medical field.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
